FDA complete response letter
Arena’s obesity treatment lorcaserin rejected by FDA
October 25, 2010Sales and Marketing Arena Pharma, Eisai, FDA, FDA complete response letter, lorcaserin, obesity
A new weight loss drug has been rejected by the FDA because of numerous concerns about side-effects and limited efficacy. …
FDA rejects Viropharma’s Cinryze manufacturing expansion
October 25, 2010Sales and Marketing Cinryze, FDA, FDA complete response letter, Viropharma, angioedema, pharmaceutical manufacturing
ViroPharma was dealt a blow late last week when the FDA turned down its application for additional manufacturing capacity for …
